Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine

MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):880-884. doi: 10.15585/mmwr.mm6840a3.

Abstract

During May 19-September 28, 2019,* low levels of influenza activity were reported in the United States, with cocirculation of influenza A and influenza B viruses. In the Southern Hemisphere seasonal influenza viruses circulated widely, with influenza A(H3) predominating in many regions; however, influenza A(H1N1)pdm09 and influenza B viruses were predominant in some countries. In late September, the World Health Organization (WHO) recommended components for the 2020 Southern Hemisphere influenza vaccine and included an update to the A(H3N2) and B/Victoria-lineage components. Annual influenza vaccination is the best means for preventing influenza illness and its complications, and vaccination before influenza activity increases is optimal. Health care providers should recommend vaccination for all persons aged ≥6 months who do not have contraindications to vaccination (1).

MeSH terms

  • Drug Resistance, Viral
  • Global Health / statistics & numerical data*
  • Humans
  • Influenza A Virus, H1N1 Subtype / drug effects
  • Influenza A Virus, H1N1 Subtype / genetics
  • Influenza A Virus, H1N1 Subtype / isolation & purification
  • Influenza A Virus, H3N2 Subtype / drug effects
  • Influenza A Virus, H3N2 Subtype / genetics
  • Influenza A Virus, H3N2 Subtype / isolation & purification
  • Influenza B virus / drug effects
  • Influenza B virus / genetics
  • Influenza B virus / isolation & purification
  • Influenza Vaccines / chemistry*
  • Influenza, Human / epidemiology*
  • Influenza, Human / virology
  • Population Surveillance*
  • Seasons
  • United States / epidemiology

Substances

  • Influenza Vaccines